Literature DB >> 1555769

Cloning of cDNAs encoding human caldesmons.

M B Humphrey1, H Herrera-Sosa, G Gonzalez, R Lee, J Bryan.   

Abstract

Caldesmon (CDM) is a potential actomyosin regulatory protein found in smooth muscle and nonmuscle cells. Domain mapping and physical studies suggest that CDM is an elongated molecule with an N-terminal myosin/calmodulin-binding domain and a C-terminal tropomyosin/actin/calmodulin-binding domain separated by a 40-nm-long central helix. An 1100-nucleotide (nt) cDNA probe encoding the C terminus of avian caldesmon (aCDM) was used to screen a human aorta library and clone smooth-muscle and non-muscle CDM-encoding cDNAs (CDM). The human (h) smooth-muscle hCDM is 3050-3630 nt long, having variation in length in the 3'-untranslated region. The predicted hCDM protein has a high degree of identity, greater than 90%, to aCDM in the N- and C-terminal-binding domains. The central helical domain is more variable, but retains characteristic repeated peptides and an 'i, i + 4' acidic/basic amino acid (aa) motif found in aCDM which can form intra-helical salt bridges to stabilize the central helix. The predicted smooth-muscle protein is 793 aa long (93,262 Da) with a calculated pI of 5.75. As is the case for the chicken, nonmuscle hCDM is missing the central helical domain, 256 aa overall. Our nonmuscle clone is not full length, but the C-terminal end is identical to the smooth-muscle form. If the N-terminal domain is identical, as it is in the chicken, the predicted protein is 537 aa (62,558 Da). Examination of the 'junctions' at either end of the deleted central domain gives a clear indication of the splice sites and suggests that the nonmuscle form is generated by exon skipping.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1555769     DOI: 10.1016/0378-1119(92)90376-z

Source DB:  PubMed          Journal:  Gene        ISSN: 0378-1119            Impact factor:   3.688


  23 in total

1.  A novel Ca2+ binding protein associated with caldesmon in Ca2+-regulated smooth muscle thin filaments: evidence for a structurally altered form of calmodulin.

Authors:  G Notarianni; N Gusev; D Lafitte; T J Hill; H S Cooper; P J Derrick; S B Marston
Journal:  J Muscle Res Cell Motil       Date:  2000       Impact factor: 2.698

2.  Activation of the Lbc Rho exchange factor proto-oncogene by truncation of an extended C terminus that regulates transformation and targeting.

Authors:  P Sterpetti; A A Hack; M P Bashar; B Park; S D Cheng; J H Knoll; T Urano; L A Feig; D Toksoz
Journal:  Mol Cell Biol       Date:  1999-02       Impact factor: 4.272

3.  Immunocytochemical localization of caldesmon and calponin in chicken gizzard smooth muscle.

Authors:  K Mabuchi; Y Li; T Tao; C L Wang
Journal:  J Muscle Res Cell Motil       Date:  1996-04       Impact factor: 2.698

4.  A short sequence within two purine-rich enhancers determines 5' splice site specificity.

Authors:  L L Elrick; M B Humphrey; T A Cooper; S M Berget
Journal:  Mol Cell Biol       Date:  1998-01       Impact factor: 4.272

5.  Differential effects of caldesmon on the intermediate conformational states of polymerizing actin.

Authors:  Renjian Huang; Zenon Grabarek; Chih-Lueh Albert Wang
Journal:  J Biol Chem       Date:  2009-11-04       Impact factor: 5.157

6.  h3/Acidic calponin: an actin-binding protein that controls extracellular signal-regulated kinase 1/2 activity in nonmuscle cells.

Authors:  Sarah Appel; Philip G Allen; Susanne Vetterkind; Jian-Ping Jin; Kathleen G Morgan
Journal:  Mol Biol Cell       Date:  2010-02-24       Impact factor: 4.138

7.  Caldesmon regulates the motility of vascular smooth muscle cells by modulating the actin cytoskeleton stability.

Authors:  Qifeng Jiang; Renjian Huang; Shaoxi Cai; Chih-Lueh A Wang
Journal:  J Biomed Sci       Date:  2010-02-03       Impact factor: 8.410

Review 8.  Smooth muscle signalling pathways in health and disease.

Authors:  H R Kim; S Appel; S Vetterkind; S S Gangopadhyay; K G Morgan
Journal:  J Cell Mol Med       Date:  2008-12       Impact factor: 5.310

9.  Effect of l-caldesmon on osteoclastogenesis in RANKL-induced RAW264.7 cells.

Authors:  Ying-Ming Liou; Chu-Lung Chan; Renjian Huang; Chih-Lueh A Wang
Journal:  J Cell Physiol       Date:  2018-03-25       Impact factor: 6.384

10.  Disulphide cross-linking of smooth-muscle and non-muscle caldesmon to the C-terminus of actin in reconstituted and native thin filaments.

Authors:  P Graceffa; L P Adam; W Lehman
Journal:  Biochem J       Date:  1993-08-15       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.